Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.
about
Recent advances in the biology and therapy of medullary thyroid carcinoma.Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Expression of somatostatin rec ...... ed with lymph node metastasis.
@en
Expression of somatostatin rec ...... ed with lymph node metastasis.
@nl
type
label
Expression of somatostatin rec ...... ed with lymph node metastasis.
@en
Expression of somatostatin rec ...... ed with lymph node metastasis.
@nl
prefLabel
Expression of somatostatin rec ...... ed with lymph node metastasis.
@en
Expression of somatostatin rec ...... ed with lymph node metastasis.
@nl
P2093
P2860
P356
P1476
Expression of somatostatin rec ...... ted with lymph node metastasis
@en
P2093
Klaus Kaserer
Markus Raderer
Merima Herac
Oskar Koperek
P2860
P304
P356
10.1111/APM.12584
P577
2016-08-19T00:00:00Z